Paul Weiss, PhD, has more than 20 years of operating experience in the biotech and pharmaceutical industries. He currently serves as a Managing Director of Venture Investors LLC, where he focuses on the firm’s therapeutics practice. Paul worked as a part-time Analyst for Venture Investors from 1989 to 1992 while receiving his MBA and joined the firm’s Investment Advisory Committee in 2001. Previously, he served as President of Venture Investors portfolio company, Gala Design, Inc., and of the Gala Biotech business unit of Cardinal Health after its acquisition. Prior to that, Paul served as Vice President of Business Development of 3-Dimensional Pharmaceuticals, a venture capital-backed company that successfully completed an IPO during his tenure, and that was subsequently acquired by Johnson & Johnson. Prior to that, Paul worked as Director of Licensing for Wyeth-Ayerst, which was a division of American Home Products (now part of Pfizer). Earlier in his career, he served as Director of Business Development and Research for the Scientific Protein Labs (SPL) division of American Home Products. He began his career in industry as the Director of Operations of Columbia Research Labs. Paul received a BS in Biochemistry with honors from Carleton University, and a PhD in Biochemistry and an MBA from the University of Wisconsin.
